Skip to content
Conditions & Health

Mitochondrial dysfunction

Impaired mitochondrial function leading to reduced cellular energy (ATP) production. Contributes to aging, neurodegeneration, and metabolic disease. Targeted by mitochondria-derived peptides SS-31, MOTS-c, and Humanin.

Frequently Asked Questions

What is Mitochondrial dysfunction?
Impaired mitochondrial function leading to reduced cellular energy (ATP) production. Contributes to aging, neurodegeneration, and metabolic disease. Targeted by mitochondria-derived peptides SS-31, MOTS-c, and Humanin.
Why is Mitochondrial dysfunction important in peptide research?
Understanding mitochondrial dysfunction is important because it represents a health condition where peptide interventions are being actively researched. Knowledge of the underlying pathology helps inform peptide selection and protocol design.

Related Terms

Oxidative stress

An imbalance between free radical production and antioxidant defenses, causing cellular damage. Mitochondrial peptides (SS-31, MOTS-c, Humanin) and GHK-Cu reduce oxidative stress through different mechanisms.

Chronic fatigue syndrome

A complex disorder characterized by extreme fatigue not explained by underlying medical conditions, worsened by physical or mental exertion. Mitochondrial peptides (SS-31, MOTS-c) and NAD+ are being explored.

Related Peptide Profiles

SS-31

Elamipretide, a mitochondria-targeted tetrapeptide that stabilizes cardiolipin in the inner mitochondrial membrane to restore cellular energy production.

MOTS-c

A mitochondria-derived peptide that regulates metabolic homeostasis by activating AMPK. Studied for exercise mimetic effects and metabolic health.

Humanin

A mitochondria-derived peptide with cytoprotective and neuroprotective properties. Studied for Alzheimer’s disease and age-related cellular stress.

NAD+

Nicotinamide adenine dinucleotide, a coenzyme essential for cellular energy metabolism, DNA repair, and sirtuin activation. Declines with age.

← Back to full glossary